Antimicrobial resistance
Antimicrobial resistance (AMR) is the resistance of a microorganism to an antimicrobial medicine to which it was previously sensitive. It develops when a microorganism mutates or acquires a resistance gene. Resistant organisms (including bacteria, viruses, fungi, protozoa and helminths) are able to withstand attack by antimicrobial medicines such as antibiotics, antivirals and antimalarials, so that standard treatments become ineffective and infections persist and may spread to other people.
About AMRTop story
WHO/Europe launches online course for clinicians on prescribing and using antibiotics wisely
WHO/Europe has launched a newly developed online course that aims to equip clinicians with the information they need to prescribe antibiotics appropriately and wisely. This free course, titled “Antimicrobial stewardship: A competency-based approach”, is available via the OpenWHO platform.
News
- Day 4 highlights: countries at the centre of health work
- Crown Princess of Denmark to address WHO/Europe’s annual meeting of ministers
- Second EVIPNet Europe cohort of countries to develop evidence-informed policy on AMR
Events
More events
Key resource
Central Asian and Eastern European Surveillance on Antimicrobial Resistance (CAESAR)A joint initiative to survey, contain and prevent the emergence and spread of antibiotic resistance in the European Region.
Read moreJoin the conversation
Publications
Central Asian and Eastern European Surveillance of Antimicrobial Resistance. Annual report 2017
More publications
Data and statistics
25 000
The number of people out of 400 000 who die every year in the European Region due to an infection with a resistant bacterial strain.
More data and statistics
